Verfügbarkeit: Law and the regulation of medicines /

Law and the regulation of medicines /:

The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is add...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Jackson, Emily, 1966-
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Oxford ; Portland, Ore. : Hart Pub., 2012.
Schlagworte:	Drugs > Law and legislation > Great Britain. Pharmacy > Law and legislation > Great Britain. Legislation, Drug > economics Clinical Trials as Topic Drug Industry > legislation & jurisprudence LAW > Administrative Law & Regulatory Practice. Drugs > Law and legislation Pharmacy > Law and legislation United Kingdom Great Britain Electronic book.
Online-Zugang:	Volltext
Zusammenfassung:	The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine''s regulation are examined separately: first, pharmacogenetics, or.
Beschreibung:	1 online resource (xvi, 292 pages)
Bibliographie:	Includes bibliographical references (pages 267-292).
ISBN:	9781847319081 1847319084 9781474200776 147420077X 9781847319098 1847319092

Internformat

MARC


LEADER	00000cam a2200000 a 4500
001	ZDB-4-EBA-ocn809536917
003	OCoLC
005	20240705115654.0
006	m o d
007	cr cnu---unuuu
008	120910s2012 enk ob 000 0 eng d
040			\|a N$T \|b eng \|e pn \|c N$T \|d CDX \|d OCLCO \|d YDXCP \|d E7B \|d OCLCQ \|d NLGGC \|d OCLCF \|d OCLCO \|d EBLCP \|d DEBSZ \|d OCLCQ \|d AGLDB \|d OCLCQ \|d OCLCO \|d OCLCA \|d VNS \|d OCLCO \|d VTS \|d OTZ \|d UAB \|d AU@ \|d REC \|d STF \|d OCLCO \|d M8D \|d OCLCQ \|d OCLCO \|d OCLCQ \|d OCLCA \|d K6U \|d OCLCQ \|d OCLCA \|d LUN \|d BLOOM \|d OCLCQ \|d OCLCO \|d OCLCQ \|d OCLCO \|d INARC \|d OCLCQ \|d OCLCO \|d OCLCL \|d SXB
019			\|a 805829861 \|a 893332401 \|a 1167640250
020			\|a 9781847319081 \|q (electronic bk.)
020			\|a 1847319084 \|q (electronic bk.)
020			\|a 9781474200776
020			\|a 147420077X
020			\|a 9781847319098 \|q (electronic book)
020			\|a 1847319092 \|q (electronic book)
020			\|z 9781849461795
020			\|z 1849461791
024	8		\|a 9786613851970
035			\|a (OCoLC)809536917 \|z (OCoLC)805829861 \|z (OCoLC)893332401 \|z (OCoLC)1167640250
037			\|a 385197 \|b MIL
043			\|a e-uk---
050		4	\|a KD3460 \|b .J33 2012eb
060		4	\|a 2012 D-928
060		4	\|a QV 33 FA1
072		7	\|a LAW \|x 001000 \|2 bisacsh
082	7		\|a 344.410416 \|2 23
049			\|a MAIN
100	1		\|a Jackson, Emily, \|d 1966- \|1 https://id.oclc.org/worldcat/entity/E39PBJwmPTFWbJkFkt8kRh89jC \|0 http://id.loc.gov/authorities/names/nr2001048551
245	1	0	\|a Law and the regulation of medicines / \|c Emily Jackson.
260			\|a Oxford ; \|a Portland, Ore. : \|b Hart Pub., \|c 2012.
300			\|a 1 online resource (xvi, 292 pages)
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
504			\|a Includes bibliographical references (pages 267-292).
505	0		\|a What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement.
588	0		\|a Print version record.
520			\|a The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine''s regulation are examined separately: first, pharmacogenetics, or.
650		0	\|a Drugs \|x Law and legislation \|z Great Britain.
650		0	\|a Pharmacy \|x Law and legislation \|z Great Britain.
650		2	\|a Legislation, Drug \|x economics
650		2	\|a Clinical Trials as Topic
650		2	\|a Drug Industry \|x legislation & jurisprudence
651		2	\|a United Kingdom
650		7	\|a LAW \|x Administrative Law & Regulatory Practice. \|2 bisacsh
650		7	\|a Drugs \|x Law and legislation \|2 fast
650		7	\|a Pharmacy \|x Law and legislation \|2 fast
651		7	\|a Great Britain \|2 fast \|1 https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP
655		4	\|a Electronic book.
758			\|i has work: \|a Law and the regulation of medicines (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCGKj4t8yYpDkhvJkRFb3DC \|4 https://id.oclc.org/worldcat/ontology/hasWork
776	0	8	\|i Print version: \|a Jackson, Emily, 1966- \|t Law and the regulation of medicines. \|d Oxford ; Portland, Ore. : Hart Pub., 2012 \|z 9781849461795 \|w (DLC) 2012406031 \|w (OCoLC)767570762
856	1		\|l FWS01 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211 \|3 Volltext
856	1		\|l CBO01 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211 \|3 Volltext
938			\|a Internet Archive \|b INAR \|n lawregulationofm0000jack
938			\|a Bloomsbury Publishing \|b BLOO \|n bpp09259369
938			\|a Coutts Information Services \|b COUT \|n 23146743 \|c 60.00 USD
938			\|a ProQuest Ebook Central \|b EBLB \|n EBL1772924
938			\|a ebrary \|b EBRY \|n ebr10589790
938			\|a EBSCOhost \|b EBSC \|n 476211
938			\|a YBP Library Services \|b YANK \|n 9562321
994			\|a 92 \|b GEBAY
912			\|a ZDB-4-EBA

Datensatz im Suchindex

DE-BY-FWS_katkey	ZDB-4-EBA-ocn809536917
_version_	1813903585612660736
adam_text
any_adam_object
author	Jackson, Emily, 1966-
author_GND	http://id.loc.gov/authorities/names/nr2001048551
author_facet	Jackson, Emily, 1966-
author_role
author_sort	Jackson, Emily, 1966-
author_variant	e j ej
building	Verbundindex
bvnumber	localFWS
callnumber-first	K - Law
callnumber-label	KD3460
callnumber-raw	KD3460 .J33 2012eb
callnumber-search	KD3460 .J33 2012eb
callnumber-sort	KD 43460 J33 42012EB
callnumber-subject	KD - United Kingdom and Ireland
collection	ZDB-4-EBA
contents	What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement.
ctrlnum	(OCoLC)809536917
dewey-full	344.410416
dewey-hundreds	300 - Social sciences
dewey-ones	344 - Labor, social, education & cultural law
dewey-raw	344.410416
dewey-search	344.410416
dewey-sort	3344.410416
dewey-tens	340 - Law
discipline	Rechtswissenschaft
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04233cam a2200733 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn809536917</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">120910s2012 enk ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">CDX</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDXCP</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VTS</subfield><subfield code="d">OTZ</subfield><subfield code="d">UAB</subfield><subfield code="d">AU@</subfield><subfield code="d">REC</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LUN</subfield><subfield code="d">BLOOM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SXB</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">805829861</subfield><subfield code="a">893332401</subfield><subfield code="a">1167640250</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781847319081</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1847319084</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781474200776</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">147420077X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781847319098</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1847319092</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781849461795</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1849461791</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a">9786613851970</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)809536917</subfield><subfield code="z">(OCoLC)805829861</subfield><subfield code="z">(OCoLC)893332401</subfield><subfield code="z">(OCoLC)1167640250</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">385197</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">e-uk---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">KD3460</subfield><subfield code="b">.J33 2012eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2012 D-928</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 33 FA1</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">001000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">344.410416</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jackson, Emily,</subfield><subfield code="d">1966-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJwmPTFWbJkFkt8kRh89jC</subfield><subfield code="0">http://id.loc.gov/authorities/names/nr2001048551</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Law and the regulation of medicines /</subfield><subfield code="c">Emily Jackson.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Oxford ;</subfield><subfield code="a">Portland, Ore. :</subfield><subfield code="b">Hart Pub.,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvi, 292 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 267-292).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine''s regulation are examined separately: first, pharmacogenetics, or.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">Great Britain.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">Great Britain.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Legislation, Drug</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="x">legislation & jurisprudence</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United Kingdom</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">Administrative Law & Regulatory Practice.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacy</subfield><subfield code="x">Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Great Britain</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Law and the regulation of medicines (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGKj4t8yYpDkhvJkRFb3DC</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Jackson, Emily, 1966-</subfield><subfield code="t">Law and the regulation of medicines.</subfield><subfield code="d">Oxford ; Portland, Ore. : Hart Pub., 2012</subfield><subfield code="z">9781849461795</subfield><subfield code="w">(DLC) 2012406031</subfield><subfield code="w">(OCoLC)767570762</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">lawregulationofm0000jack</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Bloomsbury Publishing</subfield><subfield code="b">BLOO</subfield><subfield code="n">bpp09259369</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">23146743</subfield><subfield code="c">60.00 USD</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL1772924</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10589790</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">476211</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">9562321</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection>
genre	Electronic book.
genre_facet	Electronic book.
geographic	United Kingdom Great Britain fast https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP
geographic_facet	United Kingdom Great Britain
id	ZDB-4-EBA-ocn809536917
illustrated	Not Illustrated
indexdate	2024-10-25T16:21:01Z
institution	BVB
isbn	9781847319081 1847319084 9781474200776 147420077X 9781847319098 1847319092
language	English
oclc_num	809536917
open_access_boolean
owner	MAIN
owner_facet	MAIN
physical	1 online resource (xvi, 292 pages)
psigel	ZDB-4-EBA
publishDate	2012
publishDateSearch	2012
publishDateSort	2012
publisher	Hart Pub.,
record_format	marc
spelling	Jackson, Emily, 1966- https://id.oclc.org/worldcat/entity/E39PBJwmPTFWbJkFkt8kRh89jC http://id.loc.gov/authorities/names/nr2001048551 Law and the regulation of medicines / Emily Jackson. Oxford ; Portland, Ore. : Hart Pub., 2012. 1 online resource (xvi, 292 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (pages 267-292). What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement. Print version record. The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine''s regulation are examined separately: first, pharmacogenetics, or. Drugs Law and legislation Great Britain. Pharmacy Law and legislation Great Britain. Legislation, Drug economics Clinical Trials as Topic Drug Industry legislation & jurisprudence United Kingdom LAW Administrative Law & Regulatory Practice. bisacsh Drugs Law and legislation fast Pharmacy Law and legislation fast Great Britain fast https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP Electronic book. has work: Law and the regulation of medicines (Text) https://id.oclc.org/worldcat/entity/E39PCGKj4t8yYpDkhvJkRFb3DC https://id.oclc.org/worldcat/ontology/hasWork Print version: Jackson, Emily, 1966- Law and the regulation of medicines. Oxford ; Portland, Ore. : Hart Pub., 2012 9781849461795 (DLC) 2012406031 (OCoLC)767570762 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211 Volltext
spellingShingle	Jackson, Emily, 1966- Law and the regulation of medicines / What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement. Drugs Law and legislation Great Britain. Pharmacy Law and legislation Great Britain. Legislation, Drug economics Clinical Trials as Topic Drug Industry legislation & jurisprudence LAW Administrative Law & Regulatory Practice. bisacsh Drugs Law and legislation fast Pharmacy Law and legislation fast
title	Law and the regulation of medicines /
title_auth	Law and the regulation of medicines /
title_exact_search	Law and the regulation of medicines /
title_full	Law and the regulation of medicines / Emily Jackson.
title_fullStr	Law and the regulation of medicines / Emily Jackson.
title_full_unstemmed	Law and the regulation of medicines / Emily Jackson.
title_short	Law and the regulation of medicines /
title_sort	law and the regulation of medicines
topic	Drugs Law and legislation Great Britain. Pharmacy Law and legislation Great Britain. Legislation, Drug economics Clinical Trials as Topic Drug Industry legislation & jurisprudence LAW Administrative Law & Regulatory Practice. bisacsh Drugs Law and legislation fast Pharmacy Law and legislation fast
topic_facet	Drugs Law and legislation Great Britain. Pharmacy Law and legislation Great Britain. Legislation, Drug economics Clinical Trials as Topic Drug Industry legislation & jurisprudence United Kingdom LAW Administrative Law & Regulatory Practice. Drugs Law and legislation Pharmacy Law and legislation Great Britain Electronic book.
url	https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=476211
work_keys_str_mv	AT jacksonemily lawandtheregulationofmedicines

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge